15-40737159-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018145.3(RMDN3):āc.1324A>Cā(p.Lys442Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,614,234 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018145.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RMDN3 | NM_018145.3 | c.1324A>C | p.Lys442Gln | missense_variant | 12/13 | ENST00000338376.8 | NP_060615.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RMDN3 | ENST00000338376.8 | c.1324A>C | p.Lys442Gln | missense_variant | 12/13 | 1 | NM_018145.3 | ENSP00000342493 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000596 AC: 15AN: 251480Hom.: 0 AF XY: 0.0000441 AC XY: 6AN XY: 135914
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461890Hom.: 1 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 727244
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 17, 2023 | The c.1324A>C (p.K442Q) alteration is located in exon 12 (coding exon 11) of the RMDN3 gene. This alteration results from a A to C substitution at nucleotide position 1324, causing the lysine (K) at amino acid position 442 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at